Evidence map›Paper›PMID 29637237›Full record

ArticleDer Internist2018

[Three cases of severe chronic diarrhea with a rare cause and a simple therapy].

K-P Rommel, E Schneider, I Witschel, U Halm, M Zachäus

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Der Internist, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

K-P RommelUniversitätsklinik für Kardiologie - HELIOS Stiftungsprofessur, Herzzentrum Leipzig, Strümpellstr. 39, 04289, Leipzig, Deutschland. karl-philip.rommel@medizin.uni-leipzig.de.
E SchneiderPraxis für Pathologie Dres. Schneider/Schmidt, Leipzig, Deutschland.
I WitschelKlinik für Innere Medizin, Muldentalkliniken, Krankenhaus Grimma, Grimma, Deutschland.
U HalmKlinik für Innere Medizin II/Gastroenterologie, Hepatologie, Hämatologie, Onkologie, HELIOS Park-Klinikum Leipzig, Leipzig, Deutschland.
M ZachäusKlinik für Innere Medizin II/Gastroenterologie, Hepatologie, Hämatologie, Onkologie, HELIOS Park-Klinikum Leipzig, Leipzig, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report three cases of severe olmesartan-associated chronic diarrhea with weight loss and malassimilation syndrome. Histologically, a sprue-like enteropathy was diagnosed in each case, while serological tests for celiac disease were negative. After stopping the medication, symptoms improved within a few days. Histologically, remission was documented after 3 months. Olmesartan-associated enteropathy is an underestimated entity and an important differential diagnosis in patients with chronic diarrhea.

Indexed as

Antihypertensive AgentsCeliac DiseaseDiarrheaImidazolesIntestinal DiseasesTetrazolesDiagnosis, DifferentialHumansWeight LossAntihypertensive AgentsImidazolesolmesartanTetrazolesAngiotensin receptor blockerCeliac disease, seronegativeDrug-related side effects and adverse reactionsEnteropathyOlmesartan

Identifiers

PMID29637237

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.